EA200200943A1 - Гормональная терапия рака молочной железы - Google Patents

Гормональная терапия рака молочной железы

Info

Publication number
EA200200943A1
EA200200943A1 EA200200943A EA200200943A EA200200943A1 EA 200200943 A1 EA200200943 A1 EA 200200943A1 EA 200200943 A EA200200943 A EA 200200943A EA 200200943 A EA200200943 A EA 200200943A EA 200200943 A1 EA200200943 A1 EA 200200943A1
Authority
EA
Eurasian Patent Office
Prior art keywords
breast cancer
hormonal therapy
exemestane
metastatic
hormone
Prior art date
Application number
EA200200943A
Other languages
English (en)
Other versions
EA005413B1 (ru
Inventor
Джорджо Массимини
Роберт Париданс
Жан-Пьер Лобелль
Габриэлла Пишителли
Original Assignee
Фармация Италия С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фармация Италия С.П.А. filed Critical Фармация Италия С.П.А.
Publication of EA200200943A1 publication Critical patent/EA200200943A1/ru
Publication of EA005413B1 publication Critical patent/EA005413B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Раскрыт эксеместан для применения при лечении первой линии метастатического, запущенного, гормонально зависимого рака молочной железы, в частности, у женщин в постменопаузе.Отчет о международном поиске был опубликован 2002.07.25.
EA200200943A 2000-03-03 2001-02-20 Гормональная терапия рака молочной железы EA005413B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0005257.1A GB0005257D0 (en) 2000-03-03 2000-03-03 Breast cancer hormonal therapy
PCT/EP2001/001883 WO2001064193A2 (en) 2000-03-03 2001-02-20 Exemestane for first-line treatment of breast cancer

Publications (2)

Publication Number Publication Date
EA200200943A1 true EA200200943A1 (ru) 2003-02-27
EA005413B1 EA005413B1 (ru) 2005-02-24

Family

ID=9886975

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200943A EA005413B1 (ru) 2000-03-03 2001-02-20 Гормональная терапия рака молочной железы

Country Status (22)

Country Link
US (1) US20030144259A1 (ru)
EP (1) EP1530478A2 (ru)
JP (1) JP2003525233A (ru)
KR (1) KR20020084167A (ru)
CN (1) CN1213755C (ru)
AU (1) AU2001254652A1 (ru)
BR (1) BR0108951A (ru)
CA (1) CA2401041A1 (ru)
CZ (1) CZ20022981A3 (ru)
EA (1) EA005413B1 (ru)
EE (1) EE200200479A (ru)
GB (1) GB0005257D0 (ru)
HK (1) HK1053424A1 (ru)
HR (1) HRP20020716A2 (ru)
HU (1) HUP0301123A3 (ru)
MX (1) MXPA02008574A (ru)
NO (1) NO20023971D0 (ru)
NZ (1) NZ521315A (ru)
PL (1) PL358542A1 (ru)
SK (1) SK11902002A3 (ru)
WO (1) WO2001064193A2 (ru)
ZA (1) ZA200207260B (ru)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD24Z (ru) * 2008-12-02 2010-01-31 Василе ЖОВМИР Метод дифференциального лечения неинвазивной карциномы молочной железы
MD36Z (ru) * 2008-12-02 2010-01-31 Василе ЖОВМИР Метод дифференциального лечения неинвазивной дуктальной карциномы in situ молочной железы
MD23Z (ru) * 2008-12-02 2010-01-31 Василе ЖОВМИР Метод дифференциального лечения неинвазивной лобулярной карциномы in situ молочной железы
MD35Z (ru) * 2008-12-02 2010-01-31 Василе ЖОВМИР Метод оценки риска развития неинвазивной карциномы in situ молочной железы

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002020020A1 (en) * 2000-09-08 2002-03-14 Pharmacia Italia S.P.A. Exemestane as chemopreventing agent
PT2762140T (pt) 2001-02-19 2017-07-04 Novartis Ag Resumo
SI1624878T1 (sl) * 2003-05-22 2007-02-28 Pantarhei Bioscience Bv Uporaba sestavkov, ki obsegajo estrogensko komponento, za zdravljenje in preprecevanje muskuloskeletne bolecine
WO2005027916A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and aromatase inhibitors
DE102006008074B4 (de) * 2006-02-22 2013-08-14 RUHR-UNIVERSITäT BOCHUM Behandlung von Krebs mit Geruchsrezeptor-Liganden
CN101468023B (zh) * 2007-12-26 2011-02-02 上海复星医药（集团）股份有限公司 依西美坦片及其制备工艺
KR200450538Y1 (ko) * 2008-05-29 2010-10-11 최용희 보자기형배낭

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8517360D0 (en) * 1985-07-09 1985-08-14 Erba Farmitalia Substituted androsta-1,4-diene-3,17-diones

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD24Z (ru) * 2008-12-02 2010-01-31 Василе ЖОВМИР Метод дифференциального лечения неинвазивной карциномы молочной железы
MD36Z (ru) * 2008-12-02 2010-01-31 Василе ЖОВМИР Метод дифференциального лечения неинвазивной дуктальной карциномы in situ молочной железы
MD23Z (ru) * 2008-12-02 2010-01-31 Василе ЖОВМИР Метод дифференциального лечения неинвазивной лобулярной карциномы in situ молочной железы
MD35Z (ru) * 2008-12-02 2010-01-31 Василе ЖОВМИР Метод оценки риска развития неинвазивной карциномы in situ молочной железы

Also Published As

Publication number Publication date
WO2001064193A2 (en) 2001-09-07
ZA200207260B (en) 2003-09-10
HRP20020716A2 (en) 2003-12-31
HUP0301123A3 (en) 2007-10-29
GB0005257D0 (en) 2000-04-26
NO20023971L (no) 2002-08-21
EA005413B1 (ru) 2005-02-24
SK11902002A3 (sk) 2003-05-02
US20030144259A1 (en) 2003-07-31
WO2001064193A3 (en) 2002-07-25
HK1053424A1 (en) 2003-10-24
CN1407896A (zh) 2003-04-02
NZ521315A (en) 2008-10-31
CZ20022981A3 (cs) 2003-02-12
KR20020084167A (ko) 2002-11-04
BR0108951A (pt) 2002-11-26
AU2001254652A1 (en) 2001-09-12
HUP0301123A2 (hu) 2003-08-28
JP2003525233A (ja) 2003-08-26
CN1213755C (zh) 2005-08-10
CA2401041A1 (en) 2001-09-07
EP1530478A2 (en) 2005-05-18
EE200200479A (et) 2003-12-15
PL358542A1 (en) 2004-08-09
MXPA02008574A (es) 2003-05-01
NO20023971D0 (no) 2002-08-21

Similar Documents

Publication Publication Date Title
SI1556058T1 (sl) Farmacevtski sestavki, ki obsegajo estetrolne derivate, za uporabo pri zdravljenju raka
ATE345804T1 (de) Estrogenersatztherapie
DE69928000D1 (de) Brustkrebsbehandlung mittels natürlicher ätherischer öle
GB9818916D0 (en) Use
EA200200943A1 (ru) Гормональная терапия рака молочной железы
HK1050860A1 (en) Nordihydroguaiaretic derivatives for use in treatment of tumors
WO2002058706A3 (en) Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy
BR0010702A (pt) Novas quinonas como terapias de doenças
HK1043997A1 (en) Chalcone coumarins
IS7300A (is) Notkun anastrósóls til að meðhöndla konur eftir tíðahvörf sem eru með brjóstakrabbamein á frumstigi
TR200002203T2 (tr) Lemfotoksin (LT) sentezlenme yolunun inhibitörleri kullanılarak foliküler lemfomaların tedavisi.
TR200103125T2 (tr) Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri.
TR200200278T2 (tr) Kalsilitik bileşimler
DE69912477D1 (de) Endokrintherapie für brustkrebs: kombinierte behandlung mit tamoxifen und alkyl-pcdfs
PE20020511A1 (es) Uso de antiprogestinas para la induccion de apoptosis en una celula
TW200605891A (en) Use of 7-t-butoxyiminomethylcamptothecin for the preparation of a medicament for the treatment of uterine neoplasms
张保宁 PROGNOSIS OF PATIENTS WITH BREAST CANCER RELATED TO THE TIMING OF OPERATION DURING MENSTRUAL CYCLE
UA40084A (ru) Способ лечения запущенных форм рака молочной железы без наличия отдаленных метастазов
UA34368A (ru) Способ лечения рака молочной железы
UA32800A (ru) Способ лечения неспецифических вагинитов у женщин в постменопаузе
UA32720A (uk) Спосіб внутрішнього відведення лімфи при мастектомії
UA30230A (ru) Способ лечения рака тела матки iii стадии

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU